LIPOSOMA

About LIPOSOMA

LIPOSOMA is a science-driven company specialized in lipid-based delivery systems for pharmaceuticals, nutraceuticals, medical nutrition, and immunological research.

Founded in 2014 to commercialize liposomal clodronate for immunological research, LIPOSOMA has since evolved into a dynamic group of companies, driving innovation in human health.

Today, the LIPOSOMA group consists of:

Liposoma BV; our original entity, dedicated to supporting immunological research through clodronate liposomes.

Liposoma Health BV; our innovation hub (est. 2019), focused on developing and commercializing advanced lipid-based delivery systems for nutritional, pharmaceutical, and medical applications.

Together, we deliver science-backed solutions that improve the bioavailability, stability, and efficacy of active compounds.

Keywords

• Advanced Drug Delivery
• Biopharmaceuticals
• Clodronate Liposomes
• Consulting On Application Clodronate Liposomes
• Cro/Cdmo
• Depletion Marcophages
• Immunological Research
• Lipid Nanoparticles
• Lipid-Based Formulations
• Liposomal Formulations
• Medical Nutrition & Nutraceuticals
• Nanotechnology
• Product Development
• Research & Development
• Research Liposomes
• Studying Autoimmune Diseases
• Studying Gene Therapy

Address

• Headquarters

  Science Park 4081098XH AmsterdamNoord-Holland, Netherlands

Team by function

Based on 11 public job profiles as of 4 September 2026.

• Research / R&D3
• Administrative / Office2
• Other / Unclassifiable2
• Sales2
• Founder / Owner1
• Operations1